Company · CIK 0001711279 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Krystal Biotech, Inc. · KRYS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 4, 7:15 pm EDT | Suma KrishnanPresident, R&D, Director, 10% Owner | 25,000 | $359.32 | $8,982,986 | 1,302,145 | −1.88% | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 4, 7:14 pm EDT | Krish S KrishnanPresident and CEO, Director, 10% Owner | 25,000 | $359.32 | $8,983,084 | 1,347,543 | −1.82% | 10b5-1 |
| Aug 14, 2026 SForm 4 → | Aug 14, 6:22 pm EDT | Dino A RossiDirector | 25,000 | $329.12 | $8,227,953 | 50,000 | −33.3% | |
| Aug 14, 2026 GForm 4 → | Aug 14, 6:22 pm EDT | Dino A RossiDirector | 3,691 | — | — | 75,000 | — | |
| Jun 25, 2026 SForm 4 → | Jun 26, 6:45 pm EDT | John Charles ThomasEVP, General Counsel | 1,000 | $347.27 | $347,270 | 0 | −100% | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 26, 6:45 pm EDT | John Charles ThomasEVP, General Counsel | 1,000 | $179.25 | $179,250 | 1,000 | — | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 5, 6:40 pm EDT | Suma KrishnanPresident, R&D, Director, 10% Owner | 25,000 | $308.11 | $7,702,825 | 1,378,155 | −1.78% | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 5, 6:38 pm EDT | Krish S KrishnanPresident and CEO, Director, 10% Owner | 25,000 | $308.12 | $7,702,984 | 1,450,253 | −1.69% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 AForm 4 → | Sep 16, 8:05 pm EDT | Dino A RossiDirector | 1,658 | — | — | 471 | — | |
| Sep 14, 2026 AForm 4 → | Sep 16, 8:03 pm EDT | Everett Rand SutherlandDirector | 1,658 | — | — | 471 | — | |
| Sep 14, 2026 AForm 4 → | Sep 16, 8:02 pm EDT | Catherine MazzaccoDirector | 1,658 | — | — | 471 | — | |
| Sep 14, 2026 AForm 4 → | Sep 16, 8:01 pm EDT | Christopher MasonDirector | 1,658 | — | — | 471 | — | |
| Sep 14, 2026 AForm 4 → | Sep 16, 8:01 pm EDT | Daniel JanneyDirector | 1,658 | — | — | 471 | — | |
| Sep 14, 2026 AForm 4 → | Sep 16, 8:00 pm EDT | Julian S GangolliDirector | 1,658 | — | — | 471 | — | |
| Jun 25, 2026 MForm 4 → | Jun 26, 6:45 pm EDT | John Charles ThomasEVP, General Counsel | 1,000 | — | — | 6,500 | — | 10b5-1 |